Asymptomatic carriers were reported

On 27 and 28 January 2020, the Anyang Centre for Disease Control and Prevention reported a familial cluster of cases with COVID-19, which may be caused by an asymptomatic carrier in Anyang, Henan province, China [Reference Anyang2–4]. The timeline of the onset of symptoms and asymptomatic carrier of SARS-CoV-2 that causes COVID-19 patients in a familial cluster is shown in Figure 1. On 10 January 2020, the index case, who lived in Wuhan, returned to her hometown in Anyang city to celebrate the Spring Festival with her family. This familial cluster of six cases (index case, and cases 1−5) was infected with COVID-19, and only the index case had been to Wuhan, and then her family members started to get sick one after another. However, the index case showed positive RT-PCR test results but no symptoms and normal chest computed tomography (CT) for 19 days before January 29, which is comparatively long but still within the reported maximum incubation period of 24 days [Reference Guan5]. Case 1(index case's aunt) is the earliest confirmed case in Anyang city and the only case in district A of the city. Case 1 has neither links to Wuhan nor having any history of contact with confirmed cases in the two weeks before onset, only a history of close contact with index case, who has become the only evident source of infection. Similarly, the other four cases (cases 2−5) had no epidemiological exposure in the 14-day period prior to onset, except the contact with index case, and case 2 (index case's father) and case 5 (index case's mother) are the earliest two cases in district B of the city. Therefore, the asymptomatic carrier had a relevant epidemiological history and it may be concluded that there is an asymptomatic spreader of COVID-19.

Fig. 1. Timeline of the onset of symptoms (fever, pharyngalgia, chest tightness and so on) and asymptomatic carrier of SARS-CoV-2 that causes COVID-19 in a familial cluster.

Bai et al. reported this familial cluster of cases and presumed there is a transmission of SARS-CoV-2 by an asymptomatic carrier in Anyang on 21 February 2020 [Reference Bai6]. Zhang et al. reported a familial cluster of five cases that was infected with COVID-19 in Beijing on 27 March 2020. Zhang et al. showed that the index patient remained asymptomatic for 42 days, which was much longer than the reported maximum incubation period (24 days) [Reference Zhang7]. These two family clusters of COVID-19 cases raised concerns about asymptomatic carrier transmission.

Infectivity of asymptomatic carriers

Chen Yi et al. compared the infectivity between asymptomatic carriers and symptomatic cases [Reference Chen8]. The study followed up on the close contacts of 59 imported infectious patients (51 symptomatic cases and eight asymptomatic carriers). A total of 2147 close contacts of these individuals were investigated, and among them of 132 local residents were infected (110 symptomatic cases and 22 asymptomatic cases). It was found that the total infection rate was 6.15% (132/2147), and the infection rates of close contacts of symptomatic and asymptomatic infections were 6.30% (126/2001) and 4.11% (6/146), respectively, with no statistically significant difference (P > 0.05). This was the first published quantitative study on the infectiousness of the asymptomatic transmission. Wu et al. [Reference Wu9] inferred that 126 cases (51−126) were transmitted from the symptomatic cases, while six cases (8−6) were transmitted from the asymptomatic cases. On average, each symptomatic patient could transfer the virus onto nearly three other individuals, while each asymptomatic carrier infected less than one other individual [Reference Wu9]. In other words, the transmission efficiency of the asymptomatic carrier was about 1/3 of that of the symptomatic case. However, it showed that asymptomatic infected cases with SARS-CoV-2 is highly contagious and transmitted through close contact. It is worth noting in the study that the estimation of asymptomatic transmission, according to Chen Yi et al. [Reference Chen8] and others, was based on information of close contacts who were tracked, which effectively blocked the spread of the disease through medical isolation and cutting off the transmission. Therefore, the results may be inconclusive and does not reflect all characteristics of asymptomatic spread in the real world, and the infectivity of this mode of transmission may be underestimated. The report by Chen Yi et al. had some limitations. Firstly, the infectivity was not quantified and needed more research to verify, and it was a single study with the absence of interval estimation. Secondly, it had insufficient estimates of the infectiousness of asymptomatic cases, secondary attack rate can more accurately reflect the infectiousness.

Proportion of asymptomatic carriers

Chen Yi et al. reported that asymptomatic infections accounted for 15.7% (30/191) of the total number of infections [Reference Chen8]. Japanese researchers investigated the cases on the Princess cruise ship, applied the statistical model with time-series dataset, and estimated the proportion of asymptomatic carriers in all infected cases to be 17.9% (95% CI 15.5–20.2%) [Reference Mizumoto10]. The researchers believed that their analysis underestimated the proportion of asymptomatic cases, the reasons are as follows. To begin with, most of the passengers were over 60 years old, the nature of the age distribution may lead to underestimation. Next, tests by RT-PCR were conducted with only symptomatic patients in focus at the early phase of the quarantine, and asymptomatic carriers were left out as a result of this. In addition, Japanese scholars estimated that the proportion of asymptomatic patients among infected individuals who were Japanese citizens and were evacuated out of Wuhan was 30.8% (95% CI 7.7–53.8%) [Reference Nishiura11]. There are currently three estimations of the proportion of asymptomatic cases in the whole infected population. The proportion might be much higher than the proportion of asymptomatic patients (1.0–1.2%) estimated by the majority of researchers estimated through clinical studies and other surveys conducted in the early stages of the epidemic [Reference Wu12, 13]. It should be noted that the proportion of the asymptomatic reported in most early studies comes from the proportion of existing test results, not from the proportion of the asymptomatic, so it is impossible to accurately estimate the asymptomatic infection rate. If the estimation of Japanese scholars are in line with reality, then our current proportion of asymptomatic cases is seriously underestimated. Similar to norovirus, published studies have reported that up to 30.0% of norovirus infection remains asymptomatic [Reference Phillips14, Reference Miura15], while such asymptomatically infected individuals are known to excrete substantial volume of viruses too [Reference Atmar16].

In summary, there is evidence that COVID-19 asymptomatic carrier can transmit SARS-CoV-2, and its infectivity is similar to that of symptomatic patients. So, considering the similarity of reported viral load between the asymptomatic and the symptomatic patients [Reference Zou17] and a relatively high proportion of the asymptomatic cases, the asymptomatic carriers may jeopardise efforts to contain COVID-19 transmission in public health. Because the proportion of the asymptomatic cases is underestimated and the infectiousness and prevention measures of the asymptomatic have not attracted enough attention, there will be a critical flaw in prevention and control of COVID-19. Thus, the danger of asymptomatic spread should arouse public awareness and more scientific attention into researching asymptomatic transmission in order to contribute to developing more scientific prevention and control strategy and overcoming the epidemic as soon as possible.